Jane Street Group, LLC Mersana Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 417,451 shares of MRSN stock, worth $258,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
417,451
Previous 317,332 31.55%
Holding current value
$258,819
Previous $637,000 23.7%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.23 - $2.25 $123,146 - $225,267
100,119 Added 31.55%
417,451 $788,000
Q2 2024

Aug 14, 2024
SELL
$2.0 - $4.45 $106,602 - $237,189
-53,301 Reduced 14.38%
317,332 $637,000
Q1 2024

May 15, 2024
SELL
$2.16 - $5.94 $842 - $2,316
-390 Reduced 0.11%
370,633 $1.66 Million
Q4 2023

Feb 14, 2024
BUY
$1.11 - $2.34 $108,799 - $229,362
98,018 Added 35.9%
371,023 $860,000
Q3 2023

Nov 14, 2023
SELL
$1.06 - $3.91 $43,966 - $162,178
-41,478 Reduced 13.19%
273,005 $346,000
Q2 2023

Aug 14, 2023
BUY
$3.08 - $9.55 $968,607 - $3 Million
314,483 New
314,483 $1.03 Million
Q3 2022

Nov 14, 2022
BUY
$4.63 - $8.0 $154,716 - $267,328
33,416 New
33,416 $226,000
Q2 2022

Aug 16, 2022
SELL
$2.84 - $5.0 $407,031 - $716,605
-143,321 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$3.74 - $6.63 $343,324 - $608,620
91,798 Added 178.17%
143,321 $572,000
Q4 2021

Feb 15, 2022
BUY
$5.48 - $9.86 $32,282 - $58,085
5,891 Added 12.91%
51,523 $320,000
Q3 2021

Nov 16, 2021
SELL
$8.56 - $14.47 $57,694 - $97,527
-6,740 Reduced 12.87%
45,632 $430,000
Q2 2021

Aug 16, 2021
SELL
$13.28 - $18.07 $145,588 - $198,101
-10,963 Reduced 17.31%
52,372 $712,000
Q1 2021

May 18, 2021
SELL
$15.31 - $26.52 $305,970 - $530,002
-19,985 Reduced 23.99%
63,335 $1.03 Million
Q4 2020

Feb 17, 2021
BUY
$16.84 - $27.59 $812,984 - $1.33 Million
48,277 Added 137.77%
83,320 $2.22 Million
Q3 2020

Nov 17, 2020
BUY
$16.2 - $25.7 $188,973 - $299,790
11,665 Added 49.9%
35,043 $653,000
Q2 2020

Aug 17, 2020
BUY
$5.24 - $23.4 $57,571 - $257,095
10,987 Added 88.67%
23,378 $547,000
Q1 2020

May 15, 2020
BUY
$4.41 - $9.28 $54,644 - $114,988
12,391 New
12,391 $72,000
Q3 2019

Nov 14, 2019
SELL
$1.54 - $4.2 $94,646 - $258,127
-61,459 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$3.84 - $6.4 $192,433 - $320,723
50,113 Added 441.68%
61,459 $249,000
Q1 2019

May 16, 2019
BUY
$3.51 - $7.3 $39,824 - $82,825
11,346 New
11,346 $60,000

Others Institutions Holding MRSN

# of Institutions
123
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $60.2M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email